Envela ELA 深滬

等待開盤 09-06 09:30:00 美东时间

7.465

-0.135

-1.78%

華盛通

立即下載

最高7.636
今開7.61
成交量 2.12万股
最低 7.34
昨收 7.60
總市值 1.94亿
52周最高 7.88
市盈率 ^靜 28.92
換手率 0.08%
52周最低 5.10
委比 -14.94%
總股本 2599.52万
歷史最高 28.57
量比 0.55
振幅 3.89%
歷史最低 1.33
每手 1
風險率 0.69%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Insights into Sportsman's Warehouse's Upcoming Earnings

Sportsman's Warehouse (NASDAQ:SPWH) is preparing to release its quarterly earni...

09-04 00:02
Abbvie Secures Health Canada Approval For ELAHERE Under Priority Review To Treat FRα+ Platinum-Resistant Ovarian And Related Cancers

Health Canada has approved ELAHERE®, the first novel therapy to demonstrate statistically significant and clinically meaningful improvements in overall survival (OS) compared to chemotherapy alone for patients with

09-03 00:46
触犯经销商利益，索尼·本田合资公司在美被起诉

导读：在这一争议中，“索尼·本田美国分公司是否能被视为本田汽车美国分公司的关联企业”预计将成为关注焦点。（文 / 观察者网周盛明编辑 / 高莘）据《日...

08-26 09:56
Alvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77%

Earnings Call Insights: Alvotech (ALVO) Q2 2025 Management View CEO Robert Wessman highlighted strong growth momentum in the first half of the year, citing "strong reorders, successful product launche...

08-14 23:39
B. Riley Securities Maintains Buy on Envela, Raises Price Target to $11

B. Riley Securities maintains Envela (AMEX:ELA) with a Buy and raises the price target from $10 to $11.

08-13 20:36
21.55亿，这家抗生素企业被收购！

（来源：动脉新医药）当地时间8月7日，生物制药公司CorMedix Inc. (NASDAQ:CRMD)和新型抗生素企业Melinta Therapeuti...

08-08 18:11
Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio

CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"),

08-07 19:14
Envela Q2 EPS $0.11 Beats $0.07 Estimate, Sales $54.88M Beat $46.81M Estimate

Envela (AMEX:ELA) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.07 by 69.23 percent. This is a 83.33 percent increase over earnings of $0.06 per share from the same period

08-07 04:56
What to Expect from Ardelyx's Earnings

Ardelyx (NASDAQ:ARDX) is gearing up to announce its quarterly earnings on Monda...

08-02 04:01
强生销售额超预期，盘前涨超1%

强生（J&J）季度销售额超出华尔街预期，并上调了全年业绩展望，尽管面临关税威胁和药品定价管控，仍展现出信心。强生首席财务官乔・沃尔克（Joe Wolk...

07-16 18:23

派息除權日	每股總股息	派息日期
2016-09-12	0.37	2016-09-15
2016-06-10	0.37	2016-06-15
2016-03-10	0.37	2016-03-15
2015-12-10	0.37	2015-12-15
2015-09-10	0.37	2015-09-15
2015-06-10	0.37	2015-06-15
2015-03-11	0.37	2015-03-16
2014-12-10	0.37	2014-12-15
2014-09-10	0.37	2014-09-15
2014-06-11	0.37	2014-06-15
2014-03-12	0.37	2014-03-15
2013-12-11	0.37	2013-12-16
2013-09-11	0.37	2013-09-16
2013-06-12	0.37	2013-06-17
2013-03-12	0.37	2013-03-15
2012-12-12	0.37	2012-12-15
2012-09-12	0.37	2012-09-15
2012-06-12	0.37	2012-06-15
2012-03-12	0.37	2012-03-15
2011-12-12	0.37	2011-12-15
2011-09-12	0.37	2011-09-15
2011-06-10	0.37	2011-06-15
2011-03-10	0.46	2011-03-15

公司名稱	Envela
行業分類	--
業務描述	Envela Corp. engages in recycling and re-commerce services at the forefront of the circular economy. It operates through the following segments: Consumer and Commercial. The Consumer segment focuses on selling authenticated high-end luxury goods, including pre-owned and repurposed fine jewelry, diamonds, gemstones, luxury watches, and secondary market bullion. The Commercial segment provides solutions for de-manufacturing end-of-life electronic assets, reclaiming base and precious metals, and other saleable materials. The company was founded on September 16, 1965 and is headquartered in Irving, TX.

Envela ELA 深 滬

7.465

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Envela ELA 深滬